Review article · 2025 · Open access

TREM2 and sTREM2 in Alzheimer’s disease: from mechanisms to therapies

Lianshuai Zhang, Xianyuan Xiang, Y. Li, Guojun Bu, Xiao‐Fen Chen

Molecular Neurodegeneration, 20(1), 43 · Published 17 April 2025 · DOI 10.1186/s13024-025-00834-z

Open PDFView at the publisherCite this paper

In brief

“TREM2 and sTREM2 in Alzheimer’s disease: from mechanisms to therapies” is a 2025 review article by Lianshuai Zhang and 4 co-authors, published in Molecular Neurodegeneration. OpenAlex counts 97 citations as of 20 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Molecular Neurodegeneration.

Citations
97
Most cited in
2026 (63)
Field-weighted impact
7.11
References
139
Authors
5

Abstract

Triggering receptor expressed on myeloid cells 2 (TREM2) is an innate immune receptor predominantly expressed by microglia in the brain. Recent studies have established TREM2 as a central immune signaling hub in neurodegeneration, where it triggers immune responses upon sensing pathological development and tissue damages. TREM2 binds diverse ligands and activates downstream pathways that regulate microglial phagocytosis, inflammatory responses, and metabolic reprogramming. Interestingly, TREM2 exists both in its membrane-bound form and as a soluble variant (sTREM2), that latter is generated through proteolytic shedding or alternative splicing and can be detected in cerebrospinal fluid and plasma. Emerging clinical and preclinical evidence underscores the potential of TREM2 and sTREM2 as diagnostic biomarkers and therapeutic targets in Alzheimer's disease (AD). This review provides a comprehensive overview of the molecular functions, regulatory mechanisms, and pathological implications of TREM2 and sTREM2 in AD. Furthermore, we explore their potential roles in diagnostics and therapeutics while suggesting key research directions for advancing TREM2/sTREM2-based strategies in combating AD.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Zhang, L., Xiang, X., Li, Y., Bu, G., & Chen, X. (2025). TREM2 and sTREM2 in Alzheimer’s disease: from mechanisms to therapies. Molecular Neurodegeneration, 20(1), 43. https://doi.org/10.1186/s13024-025-00834-z

MLA 9

Zhang, Lianshuai, et al. “TREM2 and sTREM2 in Alzheimer’s disease: from mechanisms to therapies.” Molecular Neurodegeneration, vol. 20, no. 1, 2025, p. 43. https://doi.org/10.1186/s13024-025-00834-z.

Chicago

Zhang, Lianshuai, Xianyuan Xiang, Y. Li, Guojun Bu, and Xiao‐Fen Chen. 2025. “TREM2 and sTREM2 in Alzheimer’s disease: from mechanisms to therapies.” Molecular Neurodegeneration 20 (1): 43. https://doi.org/10.1186/s13024-025-00834-z.

Harvard

Zhang, L. et al. (2025) ‘TREM2 and sTREM2 in Alzheimer’s disease: from mechanisms to therapies’, Molecular Neurodegeneration, 20(1), p. 43. doi:10.1186/s13024-025-00834-z.

IEEE

L. Zhang, X. Xiang, Y. Li, G. Bu, and X. Chen, “TREM2 and sTREM2 in Alzheimer’s disease: from mechanisms to therapies,” Molecular Neurodegeneration, vol. 20, no. 1, p. 43, 2025, doi: 10.1186/s13024-025-00834-z.

BibTeX

@article{zhang2025trem,
  title     = {{TREM2 and sTREM2 in Alzheimer’s disease: from mechanisms to therapies}},
  author    = {Zhang, Lianshuai and Xiang, Xianyuan and Li, Y. and Bu, Guojun and Chen, Xiao‐Fen},
  journal   = {Molecular Neurodegeneration},
  year      = {2025},
  volume    = {20},
  number    = {1},
  pages     = {43},
  doi       = {10.1186/s13024-025-00834-z},
  url       = {https://doi.org/10.1186/s13024-025-00834-z}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms

  • TREM2
  • soluble TREM2
  • Alzheimer's disease
  • microglia
  • innate immune receptors
  • neuroinflammation
  • phagocytosis
  • metabolic reprogramming

Work with this paper

Most-cited papers in Neuroscience

All highly cited Neuroscience papers

Questions about this paper

How do I cite this paper in APA style?

Zhang, L., Xiang, X., Li, Y., Bu, G., & Chen, X. (2025). TREM2 and sTREM2 in Alzheimer’s disease: from mechanisms to therapies. Molecular Neurodegeneration, 20(1), 43. https://doi.org/10.1186/s13024-025-00834-z

How many times has this paper been cited?

97 times, according to OpenAlex on 20 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Molecular Neurodegeneration: sign in and open the PDF from this page.

Who wrote this paper?

Lianshuai Zhang, Xianyuan Xiang, Y. Li, Guojun Bu, Xiao‐Fen Chen.

What is the DOI of this paper?

10.1186/s13024-025-00834-z, permanently at https://doi.org/10.1186/s13024-025-00834-z. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 20 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.